Rafferty Asset Management, LLC Heron Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.32 - $3.86 $597,539 - $994,181	257,560 New	257,560 $901,000
Q3 2022 Nov 14, 2022	SELL	$2.66 - $5.37 $406,134 - $819,902	-152,682 Reduced 20.22%	602,451 $2.54 Million
Q2 2022 Aug 12, 2022	SELL	$2.3 - $6.29 $452,994 - $1.24 Million	-196,954 Reduced 20.69%	755,133 $2.11 Million
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $1.81 Million - $3.88 Million	390,810 Added 69.63%	952,087 $5.45 Million
Q4 2021 Feb 10, 2022	BUY	$8.35 - $12.6 $2.45 Million - $3.7 Million	293,809 Added 109.85%	561,277 $5.12 Million
Q3 2021 Nov 10, 2021	BUY	$10.13 - $15.0 $993,601 - $1.47 Million	98,085 Added 57.91%	267,468 $2.86 Million
Q2 2021 Aug 10, 2021	SELL	$13.27 - $18.48 $362,390 - $504,670	-27,309 Reduced 13.88%	169,383 $2.63 Million
Q1 2021 May 10, 2021	BUY	$14.49 - $20.72 $2.36 Million - $3.37 Million	162,820 Added 480.69%	196,692 $3.19 Million
Q4 2020 Feb 10, 2021	SELL	$14.61 - $22.14 $1.1 Million - $1.66 Million	-75,112 Reduced 68.92%	33,872 $717,000
Q3 2020 Nov 13, 2020	BUY	$13.67 - $17.77 $992,195 - $1.29 Million	72,582 Added 199.39%	108,984 $1.62 Million
Q2 2020 Aug 07, 2020	BUY	$10.89 - $21.47 $282,617 - $557,189	25,952 Added 248.34%	36,402 $535,000
Q1 2020 May 15, 2020	SELL	$10.23 - $24.56 $931,236 - $2.24 Million	-91,030 Reduced 89.7%	10,450 $123,000
Q4 2019 Feb 10, 2020	SELL	$17.42 - $26.61 $297,620 - $454,631	-17,085 Reduced 14.41%	101,480 $2.39 Million
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $1.43 Million - $1.88 Million	-87,689 Reduced 42.52%	118,565 $2.19 Million
Q2 2019 Aug 09, 2019	BUY	$16.93 - $26.22 $1.32 Million - $2.04 Million	77,812 Added 60.58%	206,254 $3.83 Million
Q1 2019 May 15, 2019	BUY	$23.15 - $28.34 $2.97 Million - $3.64 Million	128,442 New	128,442 $3.14 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$28.6 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$9.47 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$9.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$8.91 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$7.48 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account